By Ben Hirschler

AMSTERDAM, Sept 2 (Reuters) - Diabetes pills known as DPP-4 therapies got a mixed safety report on Monday as studies showed they did not raise the risk of heart attacks but might be linked to heart failure, where the heart fails to pump blood adequately.

Reassuringly, the medicines were not associated with increased rates of either inflammation of the pancreas or cancer - something that has been a worry in the past.

However, in the case of AstraZeneca and Bristol-Myers Squibb's approved drug Onglyza, there was a small increase in hospitalisations for heart failure.

"It is a little bit concerning," said Dr. Christopher Grainger of Duke University Medical Center, who was not involved in the research. "I'm sure the FDA (U.S. Food and Drug Administration) will want to know more about it."

Citigroup analyst Andrew Baum, who forecasts Onglyza sales of $2.47 billion in 2018, said the latest data would not ameliorate growing pressures on the DPP-4 drug class in terms of winning reimbursement and achieving wider use.

Doctors and regulators are wary of the cardiovascular safety profile of diabetes drugs following past problems, including with GlaxoSmithKline's Avandia pill, since patients with diabetes are at increased risk of heart troubles.

Researchers from Brigham and Women's Hospital in Boston, who studied Onglyza over two years in 16,492 patients, said the heart failure finding was unexpected and deserved further investigation.

AstraZeneca and Bristol had already given headline results from the study in June, showing Onglyza did not increase heart attack risk - although it did not reduce it either, as the companies had initially hoped.

To date, researchers have been unable to identify any diabetes drug that is not only safe but actually beneficial to the heart.

Some doctors were disappointed that Onglyza and Takeda's rival drug Nesina did not reduce heart risks. However, Dr. Heinz Drexel, a heart specialist at Feldkirch Hospital in Austria and a spokesman for the European Society of Cardiology (ESC), said the idea of such a benefit from taking the medicines was "not logical".

Drexel said DPP-4s still offered several advantages, including a lack of weight gain seen with some other antidiabetics, which would offset the heart failure worries.


NO OVERALL INCREASE

Detailed results of the Onglyza study were presented at the ESC annual congress in Amsterdam, alongside a 5,380-patient study of Nesina. Both studies showing no overall increase in cardiovascular risks were published simultaneously in the New England Journal of Medicine.

The co-principal investigator on the Onglyza study, Dr. Deepak Bhatt, said he believed the heart failure issue seen with Onglyza was very likely a class effect common to all DPP-4s, adding it had probably not shown up in the Nesina trial because it was far smaller.

Still, he said the increase in heart-failure hospitalisations with Onglyza was small, affecting 3.5 percent of those taking the drug compared with 2.8 percent for the control group.

Dr. Anthony DeMaria, editor-in-chief of the Journal of the American College of Cardiology, said the absence of severe adverse events was reassuring but it might be that DPP-4s were best avoided for certain patients at high risk of heart failure.

Drugs like Onglyza and Nesina work by inhibiting dipeptidyl peptidase-4, or DPP-4, to enhance the body's ability to lower elevated levels of blood sugar.

DDP-4s are not the most powerful agents for lowering blood sugar levels but they are well tolerated and have proved an attractive option for doctors looking for new oral drugs.

The DPP-4 market is dominated by Merck's Januvia, which has annual sales of around $5 billion, including a related combination treatment called Janumet. But growth of the class has slowed this year, partly on concerns over pancreatic safety.

Onglyza, which had sales of $709 million in 2012, is a crucial product for AstraZeneca, which is banking on diabetes to help revive falling group sales due to patent expiries on several of its biggest-selling drugs.

Briggs Morrison, AstraZeneca's head of global medicines development, said the overall results of the latest trial were reassuring and the small increase in heart failure hospitalisations did not change the risk profile of the drug.

A similar heart study of Merck's Januvia in more than 14,000 patients is being conducted with results expected next year.



Also on HuffPost:




Loading Slideshow...



  • Eat Cheese


    Despite cheese's less-than-healthy reputation, a recent study in the <a href="http://www.ajcn.org/content/96/2/382.abstract" target="_hplink"><em>American Journal of Clinical Nutrition</em></a> showed that <a href="http://www.huffingtonpost.com/2012/07/27/cheese-diabetes-type-2-risk-link-_n_1699374.html?utm_hp_ref=healthy-living" target="_hplink">cheese-eaters</a> actually have a 12 percent <em>lower</em> risk of the disease than their non cheese-eating counterparts.

    Plus, people who ate more cheese, fermented milk and yogurt in the study were also more likely to have a decreased diabetes risk than people who ate less of these foods, noted the researchers, who came from Oxford University and Imperial College London.

    The people who ate the most cheese in the study consumed more than 56 grams of it per day, while those who <a href="http://www.nhs.uk/news/2012/07July/Pages/Can-a-diet-of-cheese-beat-diabetes.aspx" target="_hplink">ate the least cheese</a> in the study had fewer than 11 grams a day, the UK's NHS Choices reported.




  • Go Nuts


    Researchers from the Louisiana State University Agricultural Center found that people who <a href="http://www.huffingtonpost.com/2012/04/15/-nuts-diabetes-heart-disease_n_1423911.html" target="_hplink">regularly eat tree nuts</a> (we're talking pistachios, walnuts, almonds and cashews) have a lower risk of Type 2 diabetes, as well as heart disease and metabolic syndrome.

    Those researchers found that nut consumption is linked with lower levels of an inflammation marker called C-reactive protein (which is associated with heart disease and other chronic conditions) and higher levels of the "good" kind of cholesterol.

    In addition, people who regularly ate the tree nuts had lower body mass indexes (BMI, a ratio of height to weight) than people who didn't regularly eat nuts, the <em>Journal of the American College of Nutrition</em> study said.




  • Take A Walk


    Taking a few moments <a href="http://www.huffingtonpost.com/walking-diabetes-risk-steps_n_1637808.html" target="_hplink">for a walk each day</a> is enough to lower the risk of diabetes in high-risk people who don't regularly exercise, according to research in the journal <em>Diabetes Care</em>.

    University of Washington and University of Pittsburgh researchers found that people who walked the most in their study -- which included 1,826 people from Native American communities -- had a 29 percent lower risk of diabetes, compared with those who walked the least.

    But you didn't have to be a star walker in the study to reap the benefits -- the researchers found that 12 percent of people who took just 3,500 steps per day (there are about 2,000 steps in a mile) developed diabetes at the end of the study period, compared with 17 percent of people who <a href="http://in.reuters.com/article/2012/06/28/health-diabetes-idINL3E8HS5BR20120628" target="_hplink">walked the least</a> in the study, Reuters reported.




  • Nosh On Apples And Blueberries


    Apple, pear and blueberry eaters have lower risks of Type 2 diabetes, according to a study in the <em>American Journal of Clinical Nutrition</em>.

    The study was based on the diets of 200,000 people. HuffPost Canada reported that anthocyanins and fruits rich in anthocyanins were linked with <a href="http://www.huffingtonpost.ca/2012/03/19/apples-and-blueberries-diabetes_n_1362405.html" target="_hplink">lower diabetes risk</a>; flavanoids, however, were not.




  • Get Your Rest


    A <a href="http://care.diabetesjournals.org/content/early/2011/09/19/dc11-1093.abstract" target="_hplink"><em>Diabetes Care</em> study</a> from Children's Hospital of Philadelphia researchers showed that for obese teens, <a href="http://www.huffingtonpost.com/2011/09/20/sleep-diabetes-obese-teens_n_972505.html" target="_hplink">getting enough shut-eye</a> is linked with a lower risk of developing Type 2 diabetes.

    Researchers conducted the study on 62 obese teens. They found that sleeping between seven-and-a-half and eight-and-a-half hours a night was linked with stable glucose levels. But sleeping more or less than that was <a href="http://www.ottawasun.com/2011/09/20/lack-of-sleep-in-obese-teens-can-lead-to-diabetes-study" target="_hplink">linked with higher glucose levels</a>, the <em>Ottawa Sun</em> reported.




  • Eat Your Greens


    Eating a <a href="http://www.medicaldaily.com/news/20120427/9693/diabetes-type-2-fruit-vegetables-diet.htm" target="_hplink">range of fruits and veggies</a> could help to lower the risk of Type 2 diabetes, Medical Daily reported.

    The study, published in the <a href="http://care.diabetesjournals.org/content/early/2012/03/30/dc11-2388" target="_hplink">journal <em>Diabetes Care</em></a>, included 3,704 people. Researchers analyzed how many fruits and vegetables, as well as the variety of fruits and vegetables, they ate, along with their Type 2 diabetes status. They found that those who ate the most <em>kinds</em> of produce -- as well as just the most produce in general -- had the lowest diabetes risk, Medical Daily reported.




  • Moderate Alcohol Consumption (For Some)


    Drinking alcohol at a moderate level is linked with a <a href="http://www.reuters.com/article/2011/11/24/us-health-carbs-idUSTRE7AN1TW20111124" target="_hplink">lower risk of Type 2 diabetes</a> for some people, according to <a href="http://www.ajcn.org/content/early/2011/11/01/ajcn.111.023754" target="_hplink">an <em>American Journal of Clinical Nutrition</em> study</a>.

    Harvard researchers found that for women with refined carb-heavy diets, moderate alcohol consumption is linked with a decreased diabetes risk of 30 percent, compared with non-imbibing women who eat similar diets, Reuters reported.

    "If you eat a high carb diet without drinking alcohol, your risk of developing diabetes is increased by 30 percent," study researcher Frank Hu <a href="http://www.reuters.com/article/2011/11/24/us-health-carbs-idUSTRE7AN1TW20111124" target="_hplink">told Reuters</a>. "However, if you eat a high carb diet, but (drink) a moderate amount of alcohol, the increased risk is reduced."




  • Coffee Drinking


    Chinese researchers found earlier this year that coffee may stop a protein <a href="http://diabetes.webmd.com/news/20120113/why-coffee-may-reduce-diabetes-risk?page=2" target="_hplink">linked with Type 2 diabetes</a> from building up, thereby possibly lowering the risk of the disease, WebMD reported.

    The research, published in the <em>Journal of Agricultural and Food Chemistry</em>, suggests that three particular compounds found in coffee are able to <a href="http://diabetes.webmd.com/news/20120113/why-coffee-may-reduce-diabetes-risk?page=2" target="_hplink">have this beneficial effect</a>: caffeine, chlorogenic acid and caffeic acid, according to WebMD.




  • Diabetes Risk Factors


    Learn how to live healthy with diabetes - What risk factors are there for diabetes?